Clinical Trials Browser

Phase 1/2 × Esophageal Neoplasms × Receptor Protein-Tyrosine Kinases × Clear all

NCT00681421 2009-11-19

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer

Phase 1/2 Completed

Gastrointestinal

Esophageal Neoplasms